Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report) dropped 7.4% during trading on Friday . The company traded as low as $0.14 and last traded at $0.14. Approximately 1,000 shares were traded during trading, a decline of 73% from the average daily volume of 3,744 shares. The stock had previously closed at $0.15.
Ascletis Pharma Trading Down 7.4 %
The business has a 50-day moving average price of $0.18 and a 200 day moving average price of $0.20.
About Ascletis Pharma
Ascletis Pharma Inc, a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China and internationally. The company offers Ritonavir oral tablet, a pharmacokinetic booster of various oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid; ASCLEVIR and GANOVO for the treatment of Hepatitis C virus.
See Also
- Five stocks we like better than Ascletis Pharma
- How to buy stock: A step-by-step guide for beginners
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- Trading Halts Explained
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- Upcoming IPO Stock Lockup Period, Explained
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
